Insmed reported $22.42M in Trade Creditors for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Alexion Pharmaceuticals ALXN:US $ 125.3M 6.7M
Alimera Sciences ALIM:US $ 6.34M 1.12M
Arena Pharmaceuticals ARNA:US $ 9.55M 2.46M
Dynavax Technologies DVAX:US $ 3.15M 0.16M
Flexion Therapeutics FLXN:US $ 6.65M 278K
Heron Therapeutics HRTX:US $ 1.69M 1.16M
Insmed INSM:US $ 22.42M 20.43M
Mirati Therapeutics MRTX:US $ 19.6M 1.48M
Novartis NVS:US $ 5040M 363M
Regeneron Pharmaceuticals REGN:US $ 542.9M 67.4M
Sarepta Therapeutics SRPT:US $ 76.65M 34.44M
Seattle Genetics SGEN:US $ 108.05M 29.98M
Ultragenyx Pharmaceutical RARE:US $ 15.74M 2.82M